Procaps Issues Shareholder Letter from New CEO
MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--Feb. 5, 2024-- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a letter to shareholders from Jose Vieira , CEO of Procaps .
February 5, 2024
Procaps Group – Notice to Shareholders
MIAMI & BARRANQUILLA, Colombia .--(BUSINESS WIRE)--Jan. 16, 2024-- Dear Shareholders, We became aware on Saturday, January 13, 2024 , that the online voting instructions related to the upcoming General Meeting of Shareholders of the Company scheduled for January 22, 2024 , were incorrect.
January 16, 2024

Investor Contact Information

Company

Procaps Group
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Procaps Group Company Contact
Melissa Angelini
Investor Relations Director
ir@procapsgroup.com
mangelini@procapsgroup.com

Search Investor Relations